New York State Practitioner Education-Medical Use of Marijuana 4-hr Required Course

New York State Practitioner Education-Medical Use of Marijuana 4-hr Required Course

You are not logged in. Only partial content from this topic will be available to you. To view the full content, you must log in to your account. Don't have a login? Register now. Or, check out our Preview.

Section 3.0: The Use of Cannabis-based Products in Specific Patient Populations and Drug Interactions


Part 2

 

Drug Interactions

 

Patients suffering from multiple sclerosis, chronic pain, cancer or AIDS often take several medications concurrently. In fact, sometimes cannabis and cannabinoid- based oral medicines (e.g. dronabinol, nabilone, nabiximols) are used as adjuvant therapy to alleviate some of the symptoms associated with these various chronic diseases. Presently, we will discuss the metabolism of cannabis and cannabinoid- based medicines. Also, we will address some of the potential drug interactions between cannabinoid medicines and therapeutic agents.



Quiz icon Take a quiz related to this syllabus topic.